Ovarian aging – your questions answered

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Ovarian longevity and the significance of ovarian aging is poorly understood – our video aims to change that.

Join our Scientific Editor Daragh Campbell as she answers some of the questions that inspired her to write a report on ovarian longevity. From how the ovaries age and why it matters in the first place, to what interventions are available and the landscape of the market, our video tackles the questions that need answering.

Longevity.Technology: Ovaries set the pace for aging and changing that pace could be the key to improving fertility, healthspan and lifespan. However, the field is hampered, both by a lack of research and a lack of education; understanding the ovarian dynamic could allow more informed choices about fertility, better therapies and improved wellness in later years. Like all important discoveries, the journey starts with a question, or in the case of ovarian longevity, several questions.

“The science and research into ovarian aging has grown massively in the past five years, but very few companies are actively engaged in developing interventions,” says Longevity.Technology Scientific Editor and report author Daragh Campbell. “Discoveries are being made all over the world that need to be taken on by investors and those who can translate the science into safe and effective products. Discovering the processes involved in ovarian aging, and how to target them, will be a massive breakthrough for female healthspan and lifespan.”

Sign up for our webinar (Thu, Oct 14, 2021) – The science of ‘Ovarian longevity’ Sign up

Covered in the video:

  • How do ovaries age?
  • Why does it matter?
  • What are the current interventions?
  • What does the research show?
  • What is the market size?
  • Who are the main players?

Discoveries are being made all over the world that need to be taken on by those who can leverage the science and translate it into an actual product. Spotlighting the processes involved in ovarian aging, and how to target them, will be a massive breakthrough for female healthspan and lifespan. The time has come to ensure women can access the future they deserve – our new report on ovarian longevity is the first step on that journey.

 

Read our FREE ‘Ovarian longevity’ report.  Click here

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Buck Institute awarded $12.7m to join senescence network

NIH award to join SenNet, the Cellular Senescence Network, will enable Buck scientists to identify and characterise senescent cells – recognised as a driver...

Michael Antonov: longevity is all about tackling true unknowns

The Co-founder of Formic Ventures is using logic and innovation to drive the longevity sector forward. Michael Antonov is a serial entrepreneur and philanthropist who...

Deep learning platform seeks near-term indications of age-related diseases

Arrive co-founder talks combining aging cell biology, drug screening and deep learning technology in the quest to discover novel antiaging targets. Silicon Valley and Singapore-based...

VIDEO: The Science of Ovarian Longevity

Instead of papering over the cracks of declining fertility and the effects of menopause, what else can we do to help the longevity of...

A new approach to reversing tissue aging

Exploring Revel’s enzyme-based approach to breaking down crosslinks and targeting tissue aging. Last year, a startup called Revel Pharmaceuticals emerged from the labs at Yale...